Postmenopausal Osteoporosis (DBCOND0030339)

Identifiers

Synonyms
Osteoporosis in Postmenopausal Women / Osteoporosis in Post-menopausal Women / Osteoporosis, Postmenopausal / Postmenopausal Osteoporosis (PMO) / Postmenopausal Women With Osteoporosis / Postmenopausal Women Osteoporosis / Postmenopausal osteoporosis / Osteoporosis postmenopausal / Age-related osteoporosis without current pathological fracture / Menopausal osteoporosis (disorder) / Postmenopausal osteoporosis (disorder)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Bazedoxifene
A selective estrogen receptor modulator (SERM) used to treat moderate to severe vasomotor symptoms in menopause and osteoporosis alone or in combination with conjugated estrogens.
Calcium carbonate
An ionic compound used as a calcium supplement or antacid used for the symptomatic relief of heartburn, acid indigestion, and sour stomach.
No drug targets
Calcium gluconate
An ingredient found in a variety of supplements and vitamins, and is used to lower potassium in the blood or treat magnesium poisoning.
No drug targets
Cholecalciferol
A form of Vitamin D used in the treatment of specific medical conditions such as refractory rickets, hypoparathyroidism, and familial hypophosphatemia, as well as osteoporosis and chronic kidney disease.
Cyproterone acetate
A steroid used in combination with ethinyl estradiol to treat women with severe acne and symptoms of androgenization. Also used alone at much higher doses for palliative treatment of patients with prostate cancer
Estradiol
An estrogenic steroid used to treat vasomotor symptoms of vulvar and vaginal atrophy in menopause, hypoestrogenism, prevention of postmenopausal osteoporosis, treatment of breast cancer, and advanced androgen-dependent carcinoma of the prostate.
Estradiol valerate
An estradiol prodrug used to treat some effects of menopause, hypoestrogenism, androgen dependant carcinoma of the prostate, and in combination products for endometriosis and contraception.
Estrone sulfate
An estrogen used as monotherapy or in several combination hormone replacement products for managing menopause symptoms and hormone disorders.
Levonorgestrel
A progestin found in oral and IUD contraceptives and at higher doses in emergency contraceptives.
Medroxyprogesterone acetate
A progestin used as a contraceptive and in the treatment of secondary amenorrhea, abnormal uterine bleeding, pain from endometriosis, endometrial and renal carcinomas, paraphilia in males, and GnRH-dependent precocious puberty.
Nandrolone decanoate
An anabolic steroid indicated for the management of the anemia of renal insufficiency by increasing hemoglobin and red cell mass.
Norethisterone
A synthetic second-generation progestin used for contraception, prevention of endometrial hyperplasia in hormone replacement therapy, and in the treatment of other hormone-mediated illnesses such as endometriosis.
Norgestimate
A progesterone used as a contraceptive and to treat acne vulgaris.
Raloxifene
A selective estrogen receptor modulator that is used to prevent and treat osteoporosis and reduce the risk of invasive breast cancer in high-risk postmenopausal women.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05884372
Comparison of Efficacy of Denosumab With Eldecalcitol or Native Vitamin D in Postmenopausal Women With Osteoporosis.treatment4recruiting
NCT03162068
Cushing's Osteoporosis SpecificitiesNo drug interventionsNot AvailableNot Availableunknown_status
NCT01415050
Safety and Efficacy of Whole-body Vibration as add-on Treatment of Osteoporosis in Post-menopausal WomenNo drug interventionstreatment2completed
NCT06558188
Combined Anabolic Therapytreatment4not_yet_recruiting
NCT03227458
DHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older WomenNo drug interventionspreventionNot Availablecompleted
NCT05058976
Romosozumab Use to Build Skeletal Integritytreatment4recruiting
NCT06462833
Health Literacy's Impact on Exercise Habits and Medication Adherence in Postmenopausal OsteoporosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT04179903
Efficacy and Safety of the Physical Activity Program in Women With Post-menopausal OsteoporosisNo drug interventionsotherNot Availablecompleted
NCT03225703
The Effect of High Impact Exercise on Bone and Articular Cartilage in Post-menopausal WomenNo drug interventionsbasic_scienceNot Availableunknown_status
NCT00073190
Patient- and Physician-Based Osteoporosis EducationNo drug interventionsNot Available1completed
NCT01652690
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Denosumab (Prolia®) in Routine Clinical PracticeNot AvailableNot Availablecompleted
NCT00959764
A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Womentreatment3completed
NCT01571843
Radius Loading in Primary HyperparathyroidismNo drug interventionstreatmentNot Availablecompleted
NCT02337387
A Study of 2 Different Formulations of Blosozumab (LY2541546) in Post Menopausal Womenbasic_science1terminated
NCT03895333
Hearing Loss and OsteoporosisNo drug interventionsNot AvailableNot Availablecompleted
NCT05538377
Effect of Focal Vibration Within a Multicomponent Exercise Program for Older Women With Osteoporosis a Single-blind Clinical TrialNo drug interventionstreatmentNot Availableunknown_status
NCT00591747
Strength Training for Older Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT00532545
Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosistreatment4completed
NCT02630797
Effect of Blueberries on Bone TurnoverNo drug interventionsprevention1 / 2unknown_status
NCT02753283
Preventing Osteoporosis Using Denosumabtreatment4completed
NCT05266261
Use of Ibandronate in Diabetic PatientstreatmentNot Availablecompleted
NCT05493761
Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Diseasetreatment4recruiting
NCT02247011
A 5-Year Follow-up Study Investigating Factors Associated With Osteoporotic Fracture in Chinese Postmenopausal WomenNo drug interventionsscreeningNot Availablecompleted
NCT00965978
A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulationtreatment1completed
NCT03832088
Sarcopenia And Balance In Postmenopausal OsteoporosisNo drug interventionsdiagnosticNot Availableunknown_status
NCT04964388
Effect of GLP-1 Receptor Agonists on Trabecular Bone ScoreNo drug interventionstreatment2terminated
NCT06525688
New Biomarkers and Therapeutic Targets in Osteoporosis Via Omics TechnologiesNo drug interventionsNot AvailableNot Availablerecruiting
NCT04864509
The Effects of Melatonin Treatment on Bone, Marrow, Sleep and Blood Pressuretreatment4unknown_status
NCT00168909
Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study)treatment4completed
NCT00035256
Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosistreatment4completed
NCT03878732
Bindex for Osteoporosis DiagnosticsNo drug interventionsNot AvailableNot Availablecompleted
NCT01495000
A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumabtreatment3completed
NCT02589600
Zoledronic Acid for Osteoporotic Fracture Prevention (ZEST II)treatment4completed
NCT04029870
Psychological Determinants of the Therapeutic Observance of Osteoporotic PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00398606
A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)treatment3completed
NCT00659906
Optimizing Body Composition & Health After Breast CancerNo drug interventionssupportive_careNot Availablecompleted
NCT03701113
Milk Protein and Bone Health in Postmenopausal WomenNo drug interventionsbasic_scienceNot Availablecompleted
NCT00271713
Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)treatment4completed
NCT04798313
Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW031 and Prolia® in Healthy Adultstreatment1completed
NCT00543218
PTH Comparison in Post Menopausal Womentreatment3completed
NCT04206618
Circulating Myokine Levels and Bone MetabolismNot AvailableNot Availablecompleted
NCT00670319
Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosistreatment3completed
NCT03475719
A Clinical Trial to Evaluate the Safety and PharmacokineticNo drug interventionstreatment1unknown_status
NCT05559619
Effect of Laser Acupuncture on Forearm Bone Mineral Density and Wrist Pain in Osteoporotic Postmenopausal WomentreatmentNot Availablecompleted
NCT00402441
Risedronate in the Prevention of Osteoporosis in Postmenopausal Womenprevention4completed
NCT05025917
Assessing the Effect of Shatavari Supplementation on Bone and Skeletal Muscle Health in Healthy Postmenopausal WomenNo drug interventionsbasic_scienceNot Availablecompleted
NCT05372224
Effect of Vitamin D and Denosumab on Bone Remodelling in Women With Postmenopausal OsteoporosistreatmentNot Availablecompleted
NCT00927186
Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Womentreatment4completed
NCT00383422
Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosistreatment3completed
NCT03382366
Sarcopenia and Risk of Fall in Osteoporotic Postmenopausal WomenNo drug interventionspreventionNot Availableunknown_status
NCT00549965
Satisfaction and Compliance of Risedronate in PMOtreatment4completed
NCT04469374
Menopause Osteoporosis and Bone Intervention Using Lifestyle Exercise.No drug interventionstreatmentNot Availableterminated
NCT02472782
Adherence to Osteoporosis Treatment and Physicians' Perception Regarding Osteoporosis MedicationNot AvailableNot Availablecompleted
NCT00398931
FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051)treatment3completed
NCT00357331
The Effects of Potassium Citrate on Bone Metabolismtreatment4completed
NCT05419427
Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosistreatment3recruiting
NCT03232476
Effect of Mechanical Loading With PTH on Cortical BoneNo drug interventionsother4unknown_status
NCT01416194
Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)Not AvailableNot Availablecompleted
NCT05405894
Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab DiscontinuationNot AvailableNot Availableactive_not_recruiting
NCT05395091
Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBONDtreatment3active_not_recruiting
NCT00351091
Risedronate in Postmenopausal Women With Low Bone Densitytreatment2completed
NCT03742362
MRI Study of the Distal Radius Bone Marrow Fat Fraction in Osteoporotic and Healthy WomenNo drug interventionsotherNot Availablecompleted
NCT05228262
Vascular Function, Sarcopenia and Pain in Postmenopausal OsteoporosisNo drug interventionsbasic_scienceNot Availablerecruiting
NCT00353080
Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Womenprevention3completed
NCT03710889
Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorptiontreatment3completed
NCT04609189
Pearlium®/Effecti-Cal®, a Novel Formulation of Calcium, Vitamin D and Minerals for Prevention of Postmenopausal Bone Losstreatment4completed
NCT00405392
Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosistreatment4completed
NCT00696644
A Study for Teriparatide in Severe OsteoporosisNot AvailableNot Availablecompleted
NCT00092040
A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)treatment3completed
NCT05371340
Quercetin's Effect on Bone Health and Inflammatory MarkersNo drug interventionspreventionNot Availablecompleted
NCT03812367
Activity of Pre-Osteoclasts and Osteoclasts Over Time in Postmenopausal Women Treated With Denosumab or Zoledronic AcidNo drug interventionsNot AvailableNot Availablewithdrawn
NCT02014467
Denosumab China Phase III Studytreatment3completed
NCT00670501
Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosistreatment3completed
NCT00790101
Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuationprevention4terminated
NCT01881204
Hesperidin and Bone Health in Postmenopausal WomenNo drug interventionspreventionNot Availablecompleted
NCT00222872
3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Womentreatment1completed
NCT06375668
The Effect of the Probiotic Strains on Bone Mineral Density in Postmenopausal WomenNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT05688969
Mechanisms of Anabolic Osteoporosis TherapyNo drug interventionsotherNot Availablerecruiting
NCT00532246
Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebotreatment4completed
NCT00010712
Effects of Black Cohosh on Menopausal Hot Flashestreatment2completed
NCT01401114
Wellnara Post-marketing Surveillance in JapanNo drug interventionsNot AvailableNot Availablecompleted
NCT04167150
Tart Cherry Supplementation and Women's Bone Health StudyNo drug interventionspreventionNot Availablecompleted
NCT00543023
A Study of the Treatment of Postmenopausal Women With Osteoporosistreatment3completed
NCT03304743
Dental Panoramic Radiographs to Screen for Post-menopausal OsteoporosisNo drug interventionsNot AvailableNot Availablecompleted
NCT00130403
OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Womentreatment4completed
NCT03125590
Validation, Reliability and Pilot Test of the Personalized Exercise Questionnaire (PEQ)No drug interventionsNot AvailableNot Availablecompleted
NCT04729621
A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosistreatment3completed
NCT00542984
Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosistreatment3completed
NCT03761979
Safety and Pharmacokinetics of Orally Administered Strontium L-Lactate in Healthy AdultsNo drug interventionsotherNot Availablecompleted
NCT03623633
Comparative Antiresorptive Efficacy Discontinuation of Denosumabtreatment4active_not_recruiting
NCT05853354
Comparative Efficacy, Safety, PK, and Immunogenicity Studyother3active_not_recruiting
NCT05328154
MAGnesium Effect With ANtiosteoporotic Drugstreatment2recruiting
NCT00729651
Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263)treatment4completed
NCT01064453
Angeliq Regulatory Post Marketing SurveillanceNot AvailableNot Availablecompleted
NCT02157753
Quality of the Detection & Treatment of Osteoporotic Fractures in a Swiss Trauma CenterNo drug interventionsNot AvailableNot Availablecompleted
NCT05215977
Efficacy and Safety of MW031 in PMO SubjectsNo drug interventionstreatment3completed
NCT00018447
Combination Osteogenic Therapy in Established Osteoporosistreatment2completed
NCT02416947
Soluble Corn Fiber Effect on Bone Resorption in Post Menopausal WomenNo drug interventionspreventionNot Availablecompleted
NCT01250145
A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal Womentreatment1completed
NCT04760145
EFFECT OF FLOW RESTRICTION ON BONE QUALITY WITHIN A MULTICOMPONENT EXERCISE PROGRAM FOR OLDER WOMEN WITH OSTEOPOROSIS.No drug interventionstreatmentNot Availableunknown_status
NCT05721898
Assessment of Cortical Bone Mechanics Technology (CBMT) Fracture Discrimination CapabilityNo drug interventionsNot AvailableNot Availablecompleted
NCT04271605
Intervention on Osteoporosis and Chronic Kidney Disease-mineral and Bone Disorder (CKD-MBD)No drug interventionstreatmentNot Availableterminated
NCT04149405
Alterations of GCF Levels of Sclerostin and DKK-1 in Postmenopausal OsteoporosisNo drug interventionsdiagnostic4completed
NCT04467983
Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alonetreatment4recruiting
NCT00532428
Long Term Effects of Raloxifene Treatment on Bone Qualitytreatment4completed
NCT03337971
Nutritional Supplement and Bone Health in Post-Menopausal WomenNo drug interventionsbasic_scienceNot Availableunknown_status
NCT03091088
Effects of Physical Exercise to Prevent Osteoporosis in Postmenopausal WomenNo drug interventionstreatmentNot Availablecompleted
NCT01381588
The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal WomenNo drug interventionsNot AvailableNot Availablecompleted
NCT00532207
Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosistreatment3completed
NCT03931109
Circulating miRNA in Primary HyperparathyroidismNo drug interventionsNot AvailableNot Availablecompleted
NCT05912309
Effects of Time-restricted Eating and Exercise Training on Skeletal Muscle Mass Quantity, Quality and Function in Postmenopausal Women With Overweight and ObesityNo drug interventionstreatmentNot Availablerecruiting
NCT03268356
STRONG - Study of AGN1 LOEP for the Treatment of the Contralateral Femur After Fragility FractureNo drug interventionstreatmentNot Availablecompleted
NCT03367585
Effects of Vitamin D Supplementation in Muscle Strength and Balance TrainingNo drug interventionstreatmentNot Availablecompleted
NCT04836637
ValoRization of Dairy Sidestreams to Fight Calcium dEficits iN Postmenopausal WomenNo drug interventionspreventionNot Availablecompleted
NCT04321837
Coral Calcium's Effect on Bone Density in Postmenopausal Women With and Without Ibandronatetreatment2completed
NCT00046137
Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosistreatment3completed
NCT05402852
Effectiveness and Safety of EuBone® Capsules for Bone Health in Postmenopausal WomenNo drug interventionstreatment4unknown_status
NCT00343252
Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosistreatment3completed
NCT02090400
Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal WomenNot Available4completed
NCT03832075
Validity of Korebalance Balance SystemNo drug interventionsdiagnosticNot Availableunknown_status
NCT02109042
A Study of Blosozumab (LY2541546) in Postmenopausal Female Participantsbasic_science1completed
NCT05655013
Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis 2 (ZOLARMAB2)treatment4recruiting
NCT04063813
Parameters of Exercise to Prevent OsteoporosisNo drug interventionsbasic_scienceNot Availablecompleted
NCT00620113
Efficacy and Safety of Odanacatib (MK-0822) in Participants With Involutional Osteoporosis (MK-0822-022)treatment2completed
NCT01350934
A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)treatment4completed
NCT00632216
A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosistreatment4completed
NCT00191425
2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosistreatment4completed
NCT06487130
Virtual perI-/Menopause Registry of AusTrALiaNo drug interventionsNot AvailableNot Availablerecruiting
NCT03910348
Effects of Whole-Body Vibration and High Impact Exercises in Postmenopausal WomenNo drug interventionstreatmentNot Availablecompleted
NCT00358176
Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Womentreatment3completed
NCT03435094
Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported OutcomesNot AvailableNot Availableunknown_status
NCT04748029
Evaluation of the Prognostic Role of the Systemic Immune Inflammation Index in Postmenopausal OsteoporosisNo drug interventionsNot AvailableNot Availablecompleted
NCT00453492
Risedronate Sodium in Post Menopausal Osteoporosistreatment4completed
NCT00389740
A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)treatment3completed
NCT05575167
Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)Not AvailableNot Availablerecruiting
NCT02884401
Peri-implant Bone Changes in Post-menopausal Osteoporotic WomenNo drug interventionstreatmentNot Availablecompleted
NCT00549068
POWER Point of Care Effect on Satisfaction of Treatmenttreatment4completed
NCT01227369
Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT03158246
Generic Zoledronic Acid Versus Original Zoledronic Acid in Postmenopausal Osteoporotic Womentreatment4unknown_status
NCT00557310
A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatidetreatment4completed
NCT00088010
Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancertreatment3completed
NCT01386281
Julina Post-marketing Surveillance for Climacteric Symptoms in JapanNo drug interventionsNot AvailableNot Availablecompleted
NCT06164795
Sequential Therapies After Osteoanabolic TreatmentNot AvailableNot Availablerecruiting
NCT01397955
Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in JapanNo drug interventionsNot AvailableNot Availablecompleted
NCT01457950
A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumabtreatment3completed
NCT04974723
Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal WomenNot AvailableNot Availablecompleted
NCT04019938
Association of Cystatin C and Bone Mineral Density in Diabetic Patients.No drug interventionsNot AvailableNot Availableunknown_status
NCT03692143
Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVPNot AvailableNot Availableactive_not_recruiting
NCT06079476
A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.treatment4recruiting
NCT06577935
A Phase 2 Randomized Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasSNo drug interventionstreatment2not_yet_recruiting
NCT05010590
Anabolic Therapy in Postmenopausal Osteoporosistreatment4active_not_recruiting
NCT00545090
ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.treatment4completed
NCT00745121
Study Evaluating ASTRA TECH Implant System, OsseoSpeed™ Implants in the Upper Jaw in Women With OsteoporosisNo drug interventionstreatmentNot Availablecompleted
NCT01674621
Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosistreatment2completed
NCT00577421
Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMOtreatment3completed
NCT00545779
BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.treatment3completed
NCT03432533
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosistreatment3completed
NCT00545051
A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis.treatment4completed
NCT00381251
Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation.prevention1completed
NCT03925051
Phase 1 Study to Compare CMAB807 Injection to Prolia® in Healthy Volunteerstreatment1completed
NCT00081653
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonvivatreatment4completed
NCT02598453
PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopeniatreatment4completed
NCT00092053
Study of Investigational Drug in Osteoporosis (MK-0217-908)treatment3completed
NCT01232647
Vitamin K as Additive Treatment in Osteoporosistreatment2 / 3unknown_status
NCT00238745
Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.Not Available2completed
NCT00718861
3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrstreatment3completed
NCT00048061
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosistreatment3completed
NCT04064411
Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosistreatment3completed
NCT00984893
Intra-venous Zoledronic Acid Once YearlyNot AvailableNot Availablecompleted
NCT02822378
Dried Plums and Bone Health in Postmenopausal WomenNo drug interventionspreventionNot Availableactive_not_recruiting
NCT05902078
Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosistreatment4recruiting
NCT05433207
Post-Marketing Drug Intensive Monitoring Surveillance of EDIROL in Patients With Postmenopausal OsteoporosisNot AvailableNot Availablenot_yet_recruiting
NCT00303485
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)treatment4completed
NCT00493532
A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.Not AvailableNot Availableno_longer_available
NCT02981732
CLCF1 Gene Associated With Postmenopausal Osteoporosis of Kidney Yin Deficiency SyndromeNo drug interventionstreatmentNot Availableunknown_status
NCT04664959
A Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosistreatment3completed
NCT05060406
A Study to Evaluate the Efficacy and Safety of LY06006 in Postmenopausal Women With Osteoporosis at High Risk for FractureNo drug interventionstreatment3unknown_status
NCT00918749
Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal WomenNo drug interventionstreatment2completed
NCT00086619
Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Womentreatment2completed
NCT00377819
Study of Transitioning From Alendronate to Denosumabtreatment3completed
NCT05346419
Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal PatientstreatmentNot Availablecompleted
NCT01224717
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Womentreatment1completed
NCT02791516
A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With Osteoporosistreatment3completed
NCT00541658
A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosistreatment3completed
NCT04128163
Efficacy and Safety of QL1206 in the Treatment of Postmenopausal Osteoporosis With High Fracture RiskNo drug interventionstreatment3unknown_status
NCT03720886
G56W1 in Women With Postmenopausal Osteoporosistreatment1 / 2unknown_status
NCT02854722
The Deferasirox-calcium-vitamin D3 Therapy for Postmenopausal Osteoporosis (PMOP)treatment2unknown_status
NCT00411125
Pharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy Postmenopausal Womentreatment1completed
NCT05405725
A Phase 3 Study to Compare Biosimilar Denosumab With Prolia®treatment3unknown_status
NCT05087030
Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosistreatment3completed
NCT01128257
A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal OsteoporosisNot AvailableNot Availablecompleted
NCT05332626
Lactobacillus Acidophilus and Postmenopausal Osteoporosis WomenNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00048074
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosistreatment3completed
NCT02176382
Denosumab and Teriparatide Study (DATA-HD and DATA-EX)treatment4completed
NCT00247273
A Study of Monthly Risedronate for Osteoporosistreatment3completed
NCT00092027
A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219)treatment3completed
NCT01221727
The Effects of Denosumab on the Pharmacokinetics (PK) of Midazolamtreatment1completed
NCT04873960
Translation and Cross -Cultural Validation of ECOS-16 Questionnaire in Urdu LanguageNo drug interventionsNot AvailableNot Availablecompleted
NCT01290094
A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal Osteoporosistreatment3completed
NCT05060380
Feasibility of a Novel Resistance Exercise in Individuals With OsteoporosisNo drug interventionsotherNot Availablenot_yet_recruiting
NCT00239629
Teriparatide and Strontium Ranelate Head-To-Head Comparison Trialtreatment4completed
NCT05645289
Efficacy and Safety of Minodronate in Patients With Low Back Paintreatment4not_yet_recruiting
NCT01668589
Observational Study of Denosumab (Prolia®) in Postmenopausal Women With OsteoporosisNo drug interventionsNot AvailableNot Availablecompleted
NCT01501344
Open-label Study to Evaluate the Effect of MBP-80 on Bone RemodellingNo drug interventionspreventionNot Availablecompleted
NCT00996801
MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012)treatment2completed
NCT01343004
Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Womentreatment3completed
NCT04934072
A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With Osteoporosistreatment3completed
NCT05630768
Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Womenprevention4recruiting
NCT02422069
Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in PakistanNo drug interventionsNot AvailableNot Availablecompleted
NCT00676312
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal Subjectstreatment1completed
NCT01709110
VERtebral Fracture Treatment Comparisons in Osteoporotic Womentreatment4completed
NCT04719481
Pravastatin Reduces Acute Phase Response of Zoledronic Acidtreatment4unknown_status
NCT05571514
Study of the Impact of Mother-of-pearl Nutritional Supplementation on the Prevention of Post-menopausal OsteoporosisNo drug interventionspreventionNot Availablerecruiting
NCT02234414
Epidemiology, Identification Rate and Treatment Penetration of Osteoporotic Vertebral Fractures in SwitzerlandNo drug interventionsNot AvailableNot Availablecompleted
NCT04653350
High Intensity Multi-Modal Exercise Training in Postmenopausal WomenNo drug interventionstreatmentNot Availablecompleted
NCT06457308
Compare the Agility Exercise and Resistance Exercise on Physical Function and Stability in Osteoporotic WomenNo drug interventionspreventionNot Availablecompleted
NCT05278338
Efficacy and Safety of JMT103 in the Treatment of Postmenopausal Women With Osteoporosistreatment2unknown_status
NCT01348243
Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosistreatment3completed
NCT03970902
Quality of Life in Postmenopausal Women With OsteoporosisNo drug interventionsNot AvailableNot Availablecompleted
NCT02478879
A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pentreatment1completed
NCT00778154
Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or RisedronateNo drug interventionsNot AvailableNot Availablecompleted
NCT01572545
Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone MasstreatmentNot Availablecompleted
NCT04940845
Comparing of the Pharmacokinetic, Safety and Immunogenicity of HS-20090-2 Injection and Prolia® in Healthy Adultsprevention1unknown_status
NCT00165698
Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Womentreatment3completed
NCT01834105
Molecular Mechanism of POP Kidney Yin Deficiency Syndrome From the Interventional Effects of CLCF1health_services_research2unknown_status
NCT00936897
A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonatestreatment3completed
NCT00909961
A Trial Evaluating the Effects of Zoledronic Acid 5 mg Infusion on Bone Mineral Density (BMD) in Postmenopausal Osteoporosis (PMO) Patients Between the Ages of 50 and 65 Yearstreatment3completed
NCT00091793
Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosisprevention3completed
NCT02128009
Study on the microRNA Expression Level in Postmenopausal OsteoporosisNo drug interventionsNot AvailableNot Availablecompleted
NCT00545909
BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosistreatment4completed
NCT04026256
Bone Modeling Effects of Combined Anabolic/Antiresorptive Administrationother4completed
NCT01826656
Bone Healing in Healthy and Post-menopausal Osteoporotic WomenNo drug interventionstreatmentNot Availablewithdrawn
NCT05650437
Impact of Ultraviolet Radiation on Bone Density and Muscle Strength in Postmenopausal WomenNo drug interventionstreatmentNot Availablecompleted
NCT02499237
Zoledronic Acid to Maintain Bone Mass After Denosumab Discontinuationtreatment4completed
NCT00896532
Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Densitytreatment2completed
NCT04591275
Clinical Efficacy and Safety Comparative Study Between CMAB807 Injection and Prolia® .treatment3recruiting
NCT01732770
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosistreatment4completed
NCT00567606
Prevention of Osteoporosis in Breast Cancer SurvivorspreventionNot Availablecompleted
NCT02604836
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopeniatreatment4completed
NCT00503113
A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.treatment4completed
NCT01406613
Resolution of Effect of Bisphosphonates on Bone in Postmenopausal OsteoporosisNo drug interventionsNot AvailableNot Availablecompleted
NCT00293813
A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Densitytreatment2completed
NCT02598934
A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosistreatment4completed
NCT01575834
Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosistreatment3completed
NCT00377234
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.treatment4completed
NCT00079924
Effects of Teriparatide in Postmenopausal Women With Osteoporosistreatment4completed
NCT02016716
A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With Osteoporosistreatment3completed
NCT00545363
A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)treatment4completed
NCT01750086
Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorptiontreatment4completed
NCT01552122
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050)treatment3withdrawn
NCT02157948
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosistreatment3completed
NCT04366726
Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD)treatment1completed
NCT02347865
Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in FranceNot AvailableNot Availablecompleted
NCT00887965
A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumabsupportive_care2completed
NCT00551174
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatmenttreatment4completed
NCT05347082
Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its TreatmenttreatmentNot Availablecompleted
NCT00529373
A Study of MK-0822 in Postmenopausal Women With Osteoporosis to Assess Fracture Risk (MK-0822-018)treatment3terminated
NCT00666627
Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effectstreatment2completed
NCT03026660
Moringa Oleifera on Bone DensityNo drug interventionsbasic_scienceNot Availablecompleted
NCT04431960
Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis and CVD RiskNo drug interventionsprevention1completed
NCT01544894
Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosistreatment4completed
NCT01657162
Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosistreatment3completed
NCT00545480
SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.treatment4completed
NCT04338529
Alendronate in an Weekly Effervescent Tablet Formulation Following Denosumab DiscontinuationNot AvailableNot Availableactive_not_recruiting
NCT04169789
Prevention of Early Postmenopausal Bone Loss With Lactobacillus ReuteriNo drug interventionstreatmentNot Availablecompleted
NCT04747392
Bioequivalence Study of SAL001 and FORSTEO in Healthy Chinese Adultstreatment1completed
NCT02598440
A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosistreatment4completed
NCT06502301
How Vertebral Fractures Effect Balance In Postmenopausal WomenNo drug interventionsNot AvailableNot Availablecompleted
NCT06264401
Treatment Exercises With Core Stability and Dynamic Resistance Exercise for Postmenopausal Women With OsteoporosisNo drug interventionstreatmentNot Availablecompleted
NCT01796301
An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Womentreatment3completed
NCT04702204
Efficacy of Denosumab Treatment in Bisphosphonate Unresponsive PatientsNot AvailableNot Availablecompleted
NCT00150969
Vitamin K Supplementation in Post-Menopausal OsteopeniaNo drug interventionsprevention3completed
NCT03472846
MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosisdiagnostic4completed
NCT00890981
A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumabsupportive_care3completed
NCT00578981
Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal WomenNo drug interventionsNot AvailableNot Availablecompleted
NCT00395395
Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal Womentreatment1completed
NCT00092014
A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)treatment3completed
NCT00533650
Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)No drug interventionstreatment2completed
NCT04719650
Clinical Pharmacokinetics and Pharmacodynamics Study of Different Doses of Zoledronic Acidtreatment4not_yet_recruiting
NCT01321723
Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Womentreatment2completed
NCT03512743
Association of Serum Ferritin and Bone Mineral Density With Bone Metabolism in Chinese Healthy Postmenopausal WomenNo drug interventionsNot AvailableNot Availableunknown_status
NCT01992159
Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosistreatment2completed
NCT01249261
Effect of Stopping Risedronate After Long Term Treatment on Bone Turnovertreatment3completed
NCT03974100
Study Investigating PK, PD, Efficacy, Safety, and Immunogenicity of Biosimilar Denosumab (GP2411) in Patients With Postmenopausal Osteoporosistreatment3completed
NCT05338086
A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of MB09 [Proposed Denosumab Biosimilar] to Prolia® [EU-sourced] in Postmenopausal Osteoporosis (SIMBA Study)treatment3completed
NCT01581320
Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosistreatment3completed
NCT04757376
A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosistreatment3completed
NCT05345691
Comparison of Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab 1000 and Prolia® in Postmenopausal Women With Osteoporosistreatment3completed
NCT01631214
Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosistreatment3completed
NCT01806792
Post-menopausal Women Osteoporosis(Phase III)treatment3completed